If you experience side effects from any medication, including GLP-1 receptor agonists, you can report them through the MHRA Yellow Card scheme
Amycretin is asking a different question: what if we could make effective metabolic therapy as simple as taking a daily pill
(3) Ct I, Sakarya Y, Kirichenko N, Morgan D, Carter CS, Tmer N, Scarpace PJ
The berberine group showed significant reductions in total cholesterol and triglycerides, along with an increase in HDL cholesterol compared to the SM-only group
The FDA identifies significant risks including lack of human safety data, potential for adverse immune reactions, and insufficient evidence regarding long-term effects, with the agency authorized to take enforcement action against compounding pharmacies that produce these substances for clinical applications
(14) Bottom Line Traveling while taking a GLP-1 medication doesnt have to throw you off track, it just takes a little planning